The ceRNA mechanism is also evident in lung adenocarcinoma through the miR-590-5p/METTL3 axis [88] and in prostate cancer via modulation of PRMT5 through miR-376a-3p [94] (Fig. 2). Here, METTL3 is linked to prostate cancer.